Related Experiment Videos
[Nail pigmentation during therapy with cyclophosphamide and doxorubicin]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|June 16, 1983
Summary
Cytotoxic chemotherapy can cause nail pigmentation, appearing as streaks or diffuse discoloration. This side effect is usually reversible after discontinuing the drug.
Area of Science:
- Oncology
- Dermatology
Background:
- Cytotoxic chemotherapy is a cornerstone in treating various cancers and autoimmune diseases.
- Drug-induced side effects, including dermatological changes, are common in patients undergoing such therapies.
Observation:
- Two patients receiving cytotoxic agents (doxorubicin, cyclophosphamide) developed distinct nail pigmentation.
- One patient showed horizontal streaks, while the other had diffuse nail discoloration.
Findings:
- Nail pigmentation from cytotoxic therapy can manifest as diffuse, horizontal, or longitudinal streaks.
- These changes typically appear weeks to months after treatment initiation and often resolve after drug cessation.
- Coexisting skin or mucous membrane pigmentation may occur, and the pigmentation is more prevalent in individuals with darker skin tones.
Implications:
- Awareness of drug-induced nail pigmentation is crucial for clinicians managing patients on cytotoxic therapy.
- Monitoring for and understanding these side effects can aid in patient management and adherence.
- Further research into the obscure mechanism of nail pigmentation is warranted.